Published: 2021-12-23

Prescription audit of antihypertensive drugs used in stroke patients in a tertiary care teaching hospital

Bipin Shaji, Jereena George, Aishwarya Shrestha, Sharon Mary Stanly, Noah M. Bose


Background: Stroke is considered as one of the important reasons of death and disability worldwide. A rational use of medications is needed to prevent the recurrence and the disease related complications.

Methods: The current study is a prospective observational study. All stroke cases, with patients above the age of 25 and treated with antihypertensive agents were included in the study. A total of 189 patients were found suitable for inclusion in the study. Using a suitably designed data collection form, all pertinent data such as patient demographics, prescribed medicines, drug interactions and adverse drug reactions were collected from the patient’s case file, nurses’ charts, and medication charts. Prescription pattern of antihypertensive drugs were obtained. The causality of the ADR was assessed using the Naranjo causality assessment scale and reported in the institution where the study was conducted.

Results: Majority of patients included in the study were in the age group of 61-70 years. The incidence of stroke in this study was more in males than in the females. Ischemic stroke (72%) was more prevalent when compared to Hemorrhagic stroke. Among the antihypertensive agents, calcium channel blockers (32%) were the most commonly prescribed class of drugs. In our audit, drug related problems were observed in 27% of the cases which included cases with improper dose (3 cases), contraindications (4 cases), major drug interactions (20 cases), and adverse drug reactions (17 cases). Most of the prescriptions were legible. Drug related problems had a great impact on the overall stroketherapy.

Conclusions: The drug related problems are a relevant aspect to be considered when treating patients with stroke and it can arise irrespective of adherence to guidelines.


Stroke, Antihypertensive agents, Prescription audit, Drug interactions, Adverse drug reactions

Full Text:



Bath PM, Lees KR. Acute stroke. BMJ. 2000;320(7239):920-3.

Boehme AK, Esenwa C, Elkind MS. Stroke risk factors, genetics, and prevention. Circ Res. 2017; 120(3):472-95.

Hankey GJ. Angiotensin-converting enzyme inhibitors for stroke prevention: is there hope for progress after life?. Stroke. 2003;34(2):354-6.

Bosch J, Yusuf S, Pogue J, Sleight P, Lonn E, Rangoonwala B, et al. Use of ramipril in preventing stroke: double blind randomised trial. BMJ. 2002; 324(7339):699.

Bernd K, Stefan S. Cardiac Arrythmia following Stroke. Neurol Int. 2017;5:E8-17.

Venkateswaramurthy N, Krishnaveni K, Mercy Freeda R, Sambath KR. Assessment of potential drug–drug interaction in stroke patients. Int J Pharm Pharm Sci. 2016;8(12):221-4.

Eby M, Chandrika C, Preethy MK, Srinivasa R. A prospective observational study on prescribing trends and adverse drug reactions in stroke patients. BMJ. 2017;45:220-2.

Belhekar MN, Taur SR, Munshi RP. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions. Indian J Pharmacol. 2014;46(1):117.

Ronald GN, Fiona RS, Stone L, Lain KC. A classification of prescription errors. J Royal Coll General Pract. 1989.39:110-2.

Rai S, Bhuvana K, Soumya C, Sahana HV, Yaseen M. Prescription audit at a teritiary care teaching hospital. Nathl J Physiol Pharm Pharmacol. 2018;8(9):1271-4.

KellyHayes M. Influence of age and health behaviors on stroke risk: lessons from longitudinal studies. J Am Ger Soc. 2010;58:S325-8.

Appelros P, Stegmayr B, Terént A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009;40(4):1082-90.

Catanese L, Tarsia J, Fisher M. Acute ischemic stroke therapy overview. Circ Res. 2017;120(3):541-58.

Gupta R, Malhotra A, Malhotra P. Study of prescription pattern of drugs used in the treatment of hypertension in a teritiary care teaching hospital in North India: an observational study. Int J Res Med Sci. 2018;6:2380-4.

Celin AT, Seuma J, Ramesh A. Assessment of drug related problems in stroke patients admitted to a South Indian tertiary care teaching hospital. Indian J Pharm Pract. 2012;5(4):28-33.

Venkateswaramurthy N, Krishnaveni K, Mercy Freeda R, Sambath Kumar R. Assessment of potential drug-drug interaction in stroke patients. Int J Pharm Pharm Sci. 2016;8(12):221-4.

Ahuja MM, Deshmukh SM, Pachpohar SM, Sagat A, Nawale K, Shinde P. A study of prescription audit in inpatient department of tertiary care hospital, Pune. Indo Am J Pharma Sci. 2018;5(1):335-41.

Paudel S, Chetty MS, Laudari S, Subedi N. Adverse drug reactions of antihypertensive agents at tertiary care hospital in central Nepal. J Coll Med Sci. 2017; 13(2):284-9.

Bashir T, Zafar MZ, Ahsan M, Asim M, Abu-Huzaifa M. Study of rational and irrational prescribing in different government and private health care centres of Punjab. J Pharmacovigil. 2018;6:250.